Daniell Richard (CIK 1726096) reported 30 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-07). Recent activity: Sell TEVA (30,000 shares), Buy TEVA (17,295 shares), Sell TEVA (17,295 shares), Buy TEVA (33,512 shares), Sell TEVA (33,512 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Sell | 30,000 | $1.1M |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Buy | 17,295 | $0 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Sell | 17,295 | $547,733 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Buy | 33,512 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Sell | 33,512 | $1.1M |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Buy | 20,461 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Sell | 20,461 | $664,164 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Sell | 37,372 | $1.2M |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Buy | 62,250 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Sell | 62,250 | $2.0M |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Buy | 141,478 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Europe Commercial | Sell | 66,735 | $2.2M |
| 2025-12-11 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Buy | 100,457 | $1.9M |
| 2025-12-11 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Buy | 15,011 | $255,037 |
| 2025-12-11 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Sell | 115,468 | $3.3M |
| 2025-03-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Buy | 22,576 | $0 |
| 2025-03-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Sell | 22,576 | $359,184 |
| 2025-03-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Sell | 48,385 | $769,322 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Buy | 33,512 | $0 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Sell | 21,870 | $344,015 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Sell | 11,641 | $185,208 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Buy | 20,461 | $0 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Sell | 13,353 | $210,043 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Sell | 7,108 | $113,088 |
| 2025-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exec. VP, European Commercial | Buy | 183,169 | $0 |
Source: SEC Form 4 filings · as of 2026-05-07